SABBY 13G EBIO 2.01.16

Company

Carisma Therapeutics Inc.

Filed

February 1, 2016

Accession Number

0001535610-16-000139

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →